The Transcatheter Mitral Valve Replacement (TMVR) market is a segment of the Cardiovascular Devices industry. TMVR is a minimally invasive procedure used to replace a damaged or diseased mitral valve. It is typically used in patients who are at high risk for open-heart surgery. The procedure involves the insertion of a prosthetic valve through a catheter, which is then deployed in the heart. TMVR is a relatively new procedure, and the market is expected to grow in the coming years. The increasing prevalence of cardiovascular diseases, technological advancements, and the growing demand for minimally invasive procedures are some of the factors driving the growth of the TMVR market. Some of the major players in the TMVR market include Edwards Lifesciences, Medtronic, Abbott, Boston Scientific, and LivaNova. These companies are focused on developing innovative products and expanding their presence in the market. Show Less Read more
ASK A QUESTION
We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.
